This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Indiana University. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Jaipal Singh: Innovator in Medical Biotechnology
Introduction
Jaipal Singh is a notable inventor based in Carmel, Indiana, who has made significant contributions to the field of medical biotechnology. With a total of three patents to his name, Singh's work focuses on innovative solutions for treating various diseases, particularly those related to heart and renal health.
Latest Patents
Singh's latest patents include groundbreaking developments in the use of Modified DDAH polypeptides. These polypeptides are designed to extracorporeally treat a patient's blood to reduce levels of asymmetric dimethylarginine (ADMA). The patents detail exemplary embodiments that provide DDAH polypeptides with amino acid substitutions, additions, or deletions, which can be linked to other biologically active molecules. Additionally, his work includes compounds that modulate DDAH and ADMA levels, offering methods for treating diseases associated with these compounds.
Career Highlights
Throughout his career, Jaipal Singh has worked with esteemed institutions such as Indiana University and Endoperfusion Solutions, LLC. His research and innovations have positioned him as a key figure in the development of therapeutic strategies aimed at improving patient outcomes in cardiovascular and renal diseases.
Collaborations
Singh has collaborated with various professionals in his field, including Kerry W Fowler, enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Jaipal Singh's contributions to medical biotechnology through his innovative patents and collaborations highlight his commitment to advancing healthcare solutions. His work continues to pave the way for new treatments that can significantly improve the quality of life for patients suffering from critical health conditions.